MMR Vaccine Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast | Growth Market Reports
                     GLOBAL MMR VACCINE MARKET BY AGE GROUP 
(INFANTS AND PRESCHOOLER), BY END USER 
(HOSPITALS, CLINICS, AND HEALTHCARE 
CENTERS) AND REGION (NORTH AMERICA, LATIN 
AMERICA, EUROPE, ASIA PACIFIC AND MIDDLE 
EAST & AFRICA)
• Market Outlook:
• The global MMR vaccine market was valued at USD 697.4 Million 
in 2019 and is projected to reach USD 938.9 Million by 2027, 
expanding at a CAGR of 3.8% during the forecast period. Measles, 
mumps, and rubella (MMR) vaccines are a fusion of live viruses 
that are given as an injection. Live viruses are inactivated and 
cannot replicate in the human cells as immune system develops a 
response and defends against the infection.

• Market Dynamics
• The market is driven by factors such as rising incidences of MMR, increasing number of 
patients with autoimmune disease, growing focus on immunization programs, and increasing 
awareness among consumers for vaccine. Conversely, high cost of vaccine development and 
lack of information and unavailability of vaccines in rural areas are key restraints of this 
market. Growth of healthcare providers in emerging markets an opportunity for vaccine 
manufacturer, rise in adoption of MMR Vaccine to prevent corona virus infectious disease 
(COVID-19), and increase in adoption of combination vaccines are boosting the market.
•
Segmental Outlook
• On the basis of age group, the global MMR vaccine market is bifurcated into infants and 
preschooler. The infant segment is anticipated to expand at a CAGR of 3.7% during the 
forecast period due to rising government initiatives to decrease the prevalence of diseases 
through immunization. The preschooler segment is estimated to hold 41.0% share of the 
market in 2020 owing to its increasing effectiveness in immunity from the measles, mumps, 
and rubella.

• Based on end-users, the market is segmented into hospitals, clinics, and healthcare centers. 
The hospital segment is projected to hold a major share of the market during the forecast 
period owing to the increasing incorporation of the MMR vaccine in a majority of private and 
public hospitals globally. The healthcare centers segment is expected to grow at a substantial 
pace due to improvements in infrastructure and universal healthcare systems, especially in 
developing countries.
•
Definitions
• By Age Group
Infant: An infant is term used for the newborn baby or neonatal, and toddler. The infant age 
ranges from 12 months to 18 months are generally given the first dose of the MMR vaccine. 
In certain circumstances, infants can receive MMR vaccine from the age of 6 months, for 
example for post exposure prophylaxis Intramuscular IG (IGIM) condition. The vaccine is 
rarely repeated again, if the 1st dose is given at < 11 months of age. The repeat dose of 
MMR vaccine is not always required and is subjected to certain special cases of children. The 
immunization status of the infant or neonatal is determined in order to give the MMR vaccine 
to the baby before completing the 12months of the age. A dose provided at about 11 months 
of age (before 12 months of age) can provide sufficient immunogenic, particularly in infants 
born to mothers with vaccinated antibody measles rather than natural infection. One dose of 
MMR vaccine is 93% effective against measles, 78% effective against mumps, and 97% 
effective against rubella.
• Pre-schooler: Children aged between 4 years to 6 years are termed preschoolers. Children 
in this age group are not considered as infants. Most of the children in this age attend formal 
nursery programs. In formal nursery programs, the preschoolers usually learn basic life skills, 
independence, and basic skills require when they proceed with primary schooling. The 2nd 
dose of the MMR vaccine is usually advised to be given in this period of age to children to 
fully prevent the body from measles, mumps, and rubella virus for a lifetime. Two doses of 
MMR vaccine are 97% effective against measles and 88% effective against mumps.
•
By End User
Hospital: A hospital is a health care facility that provides patients with specialist medical and 
nursing services, and medical facilities. Hospitals are categorized as general, specialty, or 
government, depending on the source of income earned. A general hospital is the most well-
known type of hospital. It usually has an emergency ward to cater to urgent health problems 
ranging from burn and accident victims to a sudden illness. A district hospital is a healthcare 
facility having multiple beds for intensive care and additional beds for patients in need of 
long-term care. Hospitals have a number of departments (including surgery and emergency 
care) and specialist facilities including cardiology. Some hospitals have divisions for 
outpatients and others have facilities for chronic treatments. Specific units of support include 
pharmacy, pathology, and radiology.
• Clinic: A clinic (or medical clinic or hospital clinic) is a health-care facility mainly for the 
treatment of the outpatient. Clinics can be run privately or controlled and financed publicly. 
Clinics cover the primary healthcare needs of the population in local communities by 
providing specialized treatments and admitting patients for overnight stays. Clinics are 
associated with a general practice of medicine run by one or more general practitioners. 
Healthcare provided in India, China, Russia, and counties in Africa through mobile health 
clinics or roadside dispensaries.
Healthcare center: A healthcare center, health center, or community health center is a 
network of clinics staffed by a group of general practitioners and nurses providing health care 
services to individuals in a given area. Typical services covered include family practice and 
dental care; however, some healthcare centers have grown considerably and include internal 
medicine, pediatrics, women's care, family planning, pharmacy, optometry, and laboratory 
testing. In countries with facilities of universal healthcare systems, most people prefer 
treatment from the healthcare centers. Large healthcare centers in Central and Eastern 
Europe are commonly called policlinics.

• Regional Outlook
• In terms of regions, the market is fragmented into North America, 
Europe, Asia Pacific, Latin America, and Middle East & Africa. Asia 
Pacific is a promising region for the market. The region constituted 
50.0% share of the market in 2020. The market in the region is 
projected to expand at a CAGR of 4.2% during the forecast period. 
Increasing population and rising healthcare expenditure are driving 
the MMR vaccine market in Asia Pacific. The market in North 
America is projected to expand at a CAGR of 3.6% due growing 
prevalence of measles in the region.

• Competitive Landscape
• Key players in the market include GlaxoSmithKline plc., Merck & Co., Inc., Serum Institute of 
India Pvt. Ltd. These companies are considered manufacturers of MMR Vaccine based on 
their revenue, research development (R&D) activities, regional presence, and supply chain 
management system.
• The players are adopting key strategies such as acquisition, and geographical expansion 
where potential opportunity for the MMR Vaccine extraction is added in the company’s 
capacity.
• For instance, in 2020, Merck & Co., Inc. completed the acquisition of Themis, a privately-held 
company focused on vaccines and immune-modulation therapies for infectious diseases and 
cancer.
• In May 2020, GlaxoSmithKline plc. and Samsung Biologics Co. Ltd., a contract development, 
manufacturing, and analytical testing services company, entered into partnership for 
providing additional capacity of manufacturing and supplying of innovative biopharmaceutical 
therapies to former.

• Key Benefits for Industry Participants & Stakeholders
• In-depth Analysis of the Global MMR Vaccine Market
• Historical, Current and Projected Market Size in terms of Value
• Potential & Niche Segments and Regions Exhibiting Promising 
Growth Covered
• Industry Drivers, Restraints and Opportunities Covered in the 
Study
• Recent Industry Trends and Developments
• Competitive Landscape & Strategies of Key Players
• Neutral Perspective on Global MMR Vaccine Market Performance